https://www.technologynetworks.com/drug-discovery/news/parkinsons-drug-slows-als-progression-in-small-clinical-trial-374127
0
0
6/1/23 at 3:04pm
Organization
Technology Networks
Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.
Create an account
or login to join the discussion